Roubaix Capital LLC Raises Position in OrthoPediatrics Corp. $KIDS

Roubaix Capital LLC increased its stake in OrthoPediatrics Corp. (NASDAQ:KIDS) by 23.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 290,047 shares of the company’s stock after buying an additional 55,724 shares during the quarter. OrthoPediatrics comprises 2.1% of Roubaix Capital LLC’s portfolio, making the stock its 25th largest position. Roubaix Capital LLC’s holdings in OrthoPediatrics were worth $4,603,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in OrthoPediatrics by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company’s stock worth $246,000 after acquiring an additional 645 shares in the last quarter. Millennium Management LLC grew its position in OrthoPediatrics by 55.3% in the first quarter. Millennium Management LLC now owns 656,578 shares of the company’s stock valued at $16,172,000 after acquiring an additional 233,873 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in shares of OrthoPediatrics by 112.3% during the first quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock valued at $4,937,000 after purchasing an additional 106,041 shares during the period. Jane Street Group LLC acquired a new position in shares of OrthoPediatrics during the first quarter worth $389,000. Finally, American Century Companies Inc. lifted its position in shares of OrthoPediatrics by 12.5% during the second quarter. American Century Companies Inc. now owns 34,486 shares of the company’s stock worth $741,000 after purchasing an additional 3,828 shares in the last quarter. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Stock Performance

Shares of KIDS opened at $19.22 on Friday. The business’s 50 day moving average is $18.66 and its two-hundred day moving average is $17.70. OrthoPediatrics Corp. has a 52-week low of $14.42 and a 52-week high of $23.70. The firm has a market cap of $493.57 million, a price-to-earnings ratio of -11.44 and a beta of 0.99. The company has a quick ratio of 2.37, a current ratio of 5.21 and a debt-to-equity ratio of 0.29.

OrthoPediatrics (NASDAQ:KIDS) last released its earnings results on Thursday, April 30th. The company reported ($0.42) EPS for the quarter, beating the consensus estimate of ($0.46) by $0.04. OrthoPediatrics had a negative return on equity of 7.01% and a negative net margin of 16.31%.The company had revenue of $59.36 million during the quarter, compared to analysts’ expectations of $58.28 million. Analysts forecast that OrthoPediatrics Corp. will post -1.13 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

KIDS has been the subject of a number of recent analyst reports. Canaccord Genuity Group set a $25.00 price target on shares of OrthoPediatrics in a report on Friday, April 24th. BTIG Research reiterated a “buy” rating and issued a $24.00 price objective on shares of OrthoPediatrics in a report on Friday, May 1st. Truist Financial upped their price objective on shares of OrthoPediatrics from $17.00 to $20.00 and gave the company a “hold” rating in a research report on Thursday. Weiss Ratings reissued a “sell (e+)” rating on shares of OrthoPediatrics in a research report on Tuesday, April 21st. Finally, TD Cowen restated a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Nine equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $24.78.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.